BioCentury
ARTICLE | Clinical News

Micardis telmisartan: Phase IV started

October 1, 2007 7:00 AM UTC

BAY's Bayer Schering Pharma AG unit began the double-blind, European Phase IV TALENT trial in 400 patients to evaluate Adalat GITS nifedipine in combination with Pritor telmisartan, an angiotensin ...